First Houston Capital’s Bristol-Myers Squibb BMY Stock Holding History

First Houston Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,400	Closed	-$250K	–	54
2016 Q2	$250K	Buy	+3,400	New	+$240K	0.23%	57
2016 Q1	–	Sell	-3,600	Closed	-$248K	–	57
2015 Q4	$248K	Hold	3,600	–	–	0.23%	65
2015 Q3	$213K	Buy	3,600 +100	+3%	+$6.34K	0.2%	61
2015 Q2	$226K	Hold	3,500	–	–	0.2%	60
2015 Q1	$226K	Sell	3,500 -250	-7%	-$15.7K	0.2%	62
2014 Q4	$221K	Sell	3,750 -850	-18%	-$47.9K	0.2%	66
2014 Q3	$235K	Sell	4,600 -1,100	-19%	-$54.9K	0.22%	66
2014 Q2	$277K	Sell	5,700 -2,000	-26%	-$98.6K	0.27%	62
2014 Q1	$400K	Sell	7,700 -1,500	-16%	-$79.8K	0.39%	57
2013 Q4	$489K	Buy	9,200 +500	+6%	+$25.5K	0.48%	47
2013 Q3	$403K	Buy	+8,700	New	+$382K	0.43%	53

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

First Houston Capital's BMY Position: Q3 2016 in Review

First Houston Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 3,400 shares — an estimated $250K sold.

First Houston Capital first reported a position in BMY in Q3 2013 and held it in 11 quarters. The position peaked at $489K in Q4 2013. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

First Houston Capital reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
First Houston Capital sold 3,400 Bristol-Myers Squibb shares in Q3 2016, an estimated $250K.
First Houston Capital first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 11 quarters.
First Houston Capital's Bristol-Myers Squibb position peaked at $489K in Q4 2013.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on First Houston Capital's 13F filing for Q3 2016, filed 15 Nov 2016.